Baker Avenue Asset Management »

AstraZeneca shares owned by Baker Avenue Asset Management

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Baker Avenue Asset Management from 13F filings

Historical chart of Baker Avenue Asset Management investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Baker Avenue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Baker Avenue Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $203k 2.6k 77.91
2023-09-30 $35k 514 67.72
2023-06-30 $60k 832 71.57
2023-03-31 $88k 1.3k 69.41
2022-12-31 $85k 1.3k 67.80

More positions owned by Baker Avenue Asset Management

Simpson Manufacturing (SSD)
Apple (AAPL)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Ishares Tr Rus 1000 Grw Etf (IWF)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Ishares Tr Core S&p500 Etf (IVV)
Electronic Arts (EA)
Vanguard Index Fds Total Stk Mkt (VTI)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Eafe Grwth Etf (EFG)

View all positions for Baker Avenue Asset Management

Top funds holding AstraZeneca

T. Rowe Price Associates
PRIMECAP Management Company
Capital Research and Management Company - Division 3
Franklin Resources
Jennison Associates
Sanders Capital
Goldman Sachs Group
Morgan Stanley
Fisher Investments
Atlantic Trust
Bank of America Corporation
BlackRock
Capital World Investors
BlackRock
GQG Partners

View all funds holding AstraZeneca